Skip to main content

Advertisement

Log in

Endothelial cell derived factors in relation to antibodies to SSA or SSB and to endothelial cells in Sjögren's syndrome

  • Letters
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Cunliffe, W.J., Sudhakaran Menon, I. The association between cutaneous vasculitis and decreased blood fibrinolytic activity. Br J Derm 1971, 84, 99–105.

    Google Scholar 

  2. Jordan, J.M., Bates Allen, N., Pizzo, S.V. Defective release of tissue plasminogen activator in systemic and cutaneous vasculitis. Am J Med 1987, 82, 397–400.

    Article  PubMed  Google Scholar 

  3. Moussoni, L., Pintucci, G., Romano, G., De Benedetti, F., Massa, M., Martini, A. Decreased fibrinolytic activity in juvenile chronic arthritis. Ann Rheum Dis 1990, 49, 973–975.

    PubMed  Google Scholar 

  4. Nusinow, S.R., Federici, A.B., Zimmerman, T.S., Curd, J.G. Increased von Willebrand factor antigen in the plasma of patients with vasculitis. Arthritis Rheum 1984, 27, 1405–1410.

    PubMed  Google Scholar 

  5. Woolf, A.D., Wakerly, G., Wallington, T.B., Scott, D.G.I., Dieppe, P.A. Factor VIII related antigen in the assessment of vasculitis. Ann Rheum Dis 1987, 46, 441–447.

    PubMed  Google Scholar 

  6. Federici, A.B., Fox, R.I., Espinoza, L.R., Zimmerman, T.S. Elevation of von Willebrand factor is independent of erythrocyte sedimentation rate and persists after glucocorticoid treatment in giant cell arteritis. Arthritis Rheum 1984, 27, 1046–1049.

    PubMed  Google Scholar 

  7. Blann, A.D., Wainwright, A.C., Emery, P. Damage to the endothelium in Sjögren's syndrome: lack of correlation with antinuclear antibody titre and presence of antibodies to SSA or SSB. Ann Rheum Dis 1992, 51, 389–390.

    PubMed  Google Scholar 

  8. Nylander-Lundqvist, E., Bäck, O., Nilsson, T.K., Rantapää Dahlqvist, S. Prevalence of anti-endothelial cell antibodies in patients with autoimmune diseases. Clin Rheumatol 1992, 11, 248–253.

    Article  PubMed  Google Scholar 

  9. Harley, J.B., Alexander, E.L., Bias, W.B. et al. Anti-Ro (SS-A) and anti-La (SS-B) in patients with Sjögren's syndrome. Arthritis Rheum 1986, 29, 196–206.

    PubMed  Google Scholar 

  10. Alexander, E.L., Arnett, F.C., Provost, T.T., Stevens, M.B., Sjögren's syndrome: Association of anti-Ro (SS-A) antibodies with vasculitis, hematologic abnormalities, and serologic hyperreactivity. Ann Intern Med 1983, 98, 155–159.

    PubMed  Google Scholar 

  11. Homma, M., Tojo, T., Akizuki, M., Yamagata, H. Criteria for Sjögren's syndrome in Japan. Scand J Rheumatol 1986, suppl 61, 26–27.

  12. Chmielewska, J., Wiman, B. Determination of tissue plasminogen activator and its fast inhibitor from plasma. Clin Chem 1986, 32, 482–485.

    PubMed  Google Scholar 

  13. Cejka, J. Enzyme immunoassay for factor VIII-related antigen. Clin. Chem. 1982, 28, 1356–1358.

    PubMed  Google Scholar 

  14. Nilsson, T.K., Sondell, K., Norberg, B.O., Bäck, O. Plasma levels of endothelial-derived haemostatic factors in autoimmune thrombocytopenia and haemolytic anaemia. J Intern Med 1990, 228, 249–252.

    PubMed  Google Scholar 

  15. Pottinger, B.E., Read, R.C., Paleolog, E.M., Higgins, P.G., Pearson, J.D. Von Willebrand factor is an acute phase reactant in man. Thrombosis Research 1989, 53, 387–394.

    Article  PubMed  Google Scholar 

  16. Danielsson, Å., Nilsson, T.K., Uddenfeldt, P. Alternations in C1 inhibitor and clotting factor concentrations in primary biliary cirrhosis and other chronic liver diseases. Scand J Gastroenterol 1990, 25, 149–154.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rantapää-Dahlqvist, S., Nilsson, T.K. Endothelial cell derived factors in relation to antibodies to SSA or SSB and to endothelial cells in Sjögren's syndrome. Clin Rheumatol 13, 320–322 (1994). https://doi.org/10.1007/BF02249038

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02249038

Keywords

Navigation